CTTC Calmare Therapeutics Inc (CE)

FAIRFIELD, Conn., Aug. 11, 2014 /PRNewswire/ -- Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), names William Lipford, the current Midwest Regional Sales Manager for CTI, U.S. division head of product sales. In his new role, he will be responsible to direct all U.S. sales of CTI's flagship product, the Calmare® Pain Therapy device, and oversee the expansion of CTI's independent, distributor sales force across the United States.

"To effectively grow U.S. product sales with consistency, we believe internalizing sales management can help focus our efforts, increase revenues and reduce expenses," said Competitive Technologies President & CEO Conrad Mir. "We believe that such a task needs a sales professional with Bill's skill-set and discipline in the medical device sector. He stands to be an integral addition to CTI management."

This promotion replaces the consultant, sales management role of Joel Bradus, who has chosen to pursue other endeavors.

"We wish Joel success in his new opportunities," commented Mr. Mir.

Physicians interested in learning more about Calmare are encouraged to reach out to Bill Lipford at wlipford@competitivetech.net.

About Bill Lipford

Bill started his medical technologies career at Kimberly-Clark Corporation covering the Michigan and Ohio regions. He later joined Medical Development Corporation/Bard in the same region setting up distribution centers for its line of medical disposables. He set the existing sales record (2M) for the largest medical device installation in a single hospital (Michigan) facility as District Manager for Ivac Corporation/Eli Lilly, where he introduced a new IV therapy infusion device and electronic thermometry. He accomplished the same for Air Shields Corporation (Healthdyne) when he helped launch a new IV medical infusion division. At Pharmacia Corporation, he helped introduce a home programmable ambulatory infusion device for cartridge-based chemotherapy and PCA pumps (Pharmacia/Deltec). Bill acquired his extensive knowledge in selling electronic stimulation devices during his time with Zynex Medical where he served as a manufacturer's rep covering the Michigan and Ohio areas. 

Mr. Lipford has a Bachelor's degree from Michigan State University.

About the Company

Competitive Technologies Inc., the pain mitigation company, develops and commercializes innovative wound and pain management products and technologies. CTI holds the 510k clearance on its flagship product, the non-invasive Calmare^® Pain Therapy Device, which grants it an exclusive right to sell, market, research and develop the medical device. The Company is the exclusive licensed global distributor of Calmare.

Forward-Looking Statement

Certain statements contained in this press release are forward-looking statements that involve risks and uncertainties. The statements contained herein that are not purely historical are forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements deal with the Company's current plans, intentions, beliefs and expectations and statements of future economic performance. Forward-looking statements involve known and unknown risks and uncertainties that may cause the Company's actual results in future periods to differ materially from what is currently anticipated. Factors that could cause or contribute to such differences include those discussed from time to time in reports filed by the Company with the Securities and Exchange Commission. The Company cannot guarantee its future results, levels of activity, performance or achievements.

www.competitivetech.net

SOURCE Competitive Technologies, Inc.